The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin

• Status: Completed
• Trial end date: 2015-10-01
• Target enrollment: 0
• Participant gender: Male

Summary

This study will investigate the non-growth-hormone-dependent metabolic effects of the hormone Ghrelin in growth hormone deficient subjects by examining the insulin tolerance as well as signal proteins in fat and muscle biopsies.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Aarhus
• Treatments: Acipimox

Criteria

Inclusion Criteria:

• males with hypopituitarism in regard to growth hormone and ACTH in stabile treatment regime

• age 18-65

• BMI 20-35

Exclusion Criteria:

• abuse of alcohol

• malign disease

• medication other than that expected for hypopituitarism

• known disease other than hypopituitarism

• participation in isotope investigations the last 6 months